[1. Metra M, Ponikowski P, Beckenstein K et al. Advanced chronic heart failure: a position statement from the study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology, Eur J Heart Fail. 2007, 9: 684-9410.1016/j.ejheart.2007.04.00317481947]Search in Google Scholar
[2. Allen LA, Stevenson LW, Grady KL et al – Decesion making in advanced heart failure: a scientific statement from the American Heart Association, Circulation 2012, 125 (15): 1928-5210.1161/CIR.0b013e31824f2173389370322392529]Search in Google Scholar
[3. Fang JC – Advanced (stage D) heart failure: a statement from the Heart Failure Society of America guidelines committee, J Card Fail 2015, 21 (6):519-34]Search in Google Scholar
[4. Crespo-Leriro MG et al – Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology, Eur J Heart Fail. 2018, 20: 1505-153510.1002/ejhf.123629806100]Open DOISearch in Google Scholar
[5. Abonezzedine OF, Redfield MM – Who has advanced Heart Failure? Definition and epidemiology, Congest. Heart Fail 2011,17 4): 160-810.1111/j.1751-7133.2011.00246.x385775921790965]Search in Google Scholar
[6. Metra M, Dinatolo E, Dasseni A – The New Hear Failure Association. Definition of Advanced Heart Failure, Cardiac Failure Rew 2019, 5(1): 5-810.15420/cfr.2018.43.1639606030847238]Search in Google Scholar
[7. Fonarow GC, Yancy CW, hernandez AF et al – Potential impact of optional implementation of evidece-based heart failure therapy on mortality, Am Heart J 2011, 161(6):1024-3010.1016/j.ahj.2011.01.02721641346]Search in Google Scholar
[8. Ginwalla M, Tofovic – Current status of inotropes in heart failure, Heart Failure Clin 2018,14: 601-61610.1016/j.hfc.2018.06.01030266368]Search in Google Scholar
[9. Hashim T, Sanam K, Ravilla-Martinez et al – Clinical characteristics and outcomes of intravenous inotropic therapy in advanced heart failure, Circ Heart Failure 2015, 8:880-88610.1161/CIRCHEARTFAILURE.114.00177826179184]Search in Google Scholar
[10. Rose EA, Gelinjns AC, Moskowitz AJ et al – Long term use of left ventricular assist device for end-stage heart failure. The Randomized Evaluation of the Mechanical Assistance the Treatment of Congestive Heart Failure (REMATCH) Study Group, N Engl J Med 2001, 345(20):1435-43]Search in Google Scholar
[11. Rogers JG, Butler J, Lansman SL et al – Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial, J Am Coll Cardiol 2007, 50 (8) 241-710.1016/j.jacc.2007.03.06317707178]Search in Google Scholar
[12. Brignole M, Auricchio A, Baron-Esquivias G et al – Guidelines on cardiac pacieng and cardiac resynchronization therapy: the Tark Force on Cardiac Pacing and Desyncronization Therapy of the European Society of Cardiologie (ESC). Developed in collaboration with the European heart Rhythm Association (EHRA), Eur Heart J 2013, 34: 2281-39210.1093/eurheartj/eht15023801822]Search in Google Scholar
[13. Bariani G, Nesti M, Ziacchi M et al – Cardiac resyncronization on therapy: an Overview on Guidelines, Hear Fail Clin 2017, 13:117-23710.1016/j.hfc.2016.07.010]Search in Google Scholar
[14. Abraham WT, Fisher WG, Smith AL et al – Cardiac resyncronization in chronic heart failure, N Engl J Med 2002, 376(24:1845-53]Search in Google Scholar
[15. Linde C, Abraham WT, Gold MR et al – Randomized trial of resyncronization in midly symptomatic Heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure sumptoms, J Am Coll Card 2008,52:1834-4310.1016/j.jacc.2008.08.027]Search in Google Scholar
[16.Mc Alister FA, Ezekowitz J – Cardiac resyncronization therapy for patients with left ventricular systolic disfunction, JAMA 2007,22: 2502-251410.1001/jama.297.22.2502]Open DOISearch in Google Scholar
[17. Frohlich GH, Holzmeister J, Hubler M et al – Prophylactic implantable carioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation, Heart 2013, 99:1158-116510.1136/heartjnl-2013-304185]Search in Google Scholar
[18. Chaudhry Sunit-Preet, Stewart GC – Advanced Heart Failure: Prevalence, Natural Hystory and Prognostic, Heart Failure Clin 2016, 12:323-33310.1016/j.hfc.2016.03.001]Search in Google Scholar
[19. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients, with reduce left ventricular efective fraction. The SOLVD Investigators, N Engl Med 1992, 327(10): 682-9110.1056/NEJM199209033271003]Search in Google Scholar
[20. Greenberg B, Lottes SR, Nelson JJ et al – Predictors of clinical outcomes in patients given carvedilol for heart failure, Am J Cardiol 2006, 98 (1): 1480-410.1016/j.amjcard.2006.06.050]Search in Google Scholar
[21. Corra U, Agostoni PG, Anker SD et al – Role of cardiopulmonary exercise test in clinical stratification in heart failure, Eur J Heart Fail. 2018, 20, 3-1510.1002/ejhf.979]Search in Google Scholar
[22. Cacciatore F, Abete P, Mazzarella F et al – Fraily predicts log-term mortality in elderly subjects with chronic heart failure, Eur J Clin Invest 2005, 35 (12):723-3010.1111/j.1365-2362.2005.01572.x]Search in Google Scholar
[23. DI Salvo TG, Mathier M, Semigran MJ et al – Preserved right ventricular ejection fraction predicts exercise capacity ane survival in advanced heart failure, J Am Coll Cardiol 1995, 25 (5): 1143-5810.1016/0735-1097(94)00511-N]Search in Google Scholar
[24. Doust JA, Pietrzak E, Dobson A et al. How well does B-type natriuretic peptide predicts death and cardiac events in patients with heart failure: systematic review, BMJ 2005, 330(7492): 62510.1136/bmj.330.7492.625]Search in Google Scholar
[25. Lee WH, Parker M – Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patiets with severe heart failure, Circulation 1986, 73(2): 257-6710.1161/01.CIR.73.2.257]Search in Google Scholar
[26. Cutbert JJ, Pellicori P, Rigby et al – Low serum chloride in patients with chronic heart failure: clinical association and prognostic significance, Eur J Heart Fail 2018, 20:1426-3510.1002/ejhf.1247]Search in Google Scholar
[27. Bock JS, Gottlich SS – Cardiorenal syndrome: new perspectives, Circulation 2010, 121 (23): 2592-60010.1161/CIRCULATIONAHA.109.886473]Search in Google Scholar
[28 Kirklin JK, Naflel BC, Kormos RL et al – Quantifying the effect of cardiorenal syndrome on mortality after left ventricular assist device implant, J Heart Lung Transplant 2013, 321 (21): 1205-1310.1016/j.healun.2013.09.001]Search in Google Scholar
[29. Kiftleson M, Hurwitz S, Shah MR et al – Development of circulatory renal limitation to angiotensin-converting enzyma inhibitors identifies patients with severe heart failure and early mortality, J Am Coll Cardiol 2003, 41 ((11): 2029-3510.1016/S0735-1097(03)00417-0]Search in Google Scholar
[30 Levy WC, Mozaffarian D, Linker DT et al – The Seattle Heart Failure model: predictor of survival in heart failure, Circulation 2006, 113 (11):1424-3310.1161/CIRCULATIONAHA.105.58410216534009]Search in Google Scholar
[31. Rusinaru D, Tribouilloy C, Berry C et al – Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis: meta analysis global group in chronic heart failure (MAGGIC), Eur J Heart Fail 2013, 141 (10): 1139-46.10.1093/eurjhf/hfs09922782968]Search in Google Scholar
[32. Wagas M, Cowger JA – Role of durable mechanical circulatory support for the management of advanced heart failure, Heart Fail clin 2013,12:399-40910.1016/j.hfc.2016.03.01227371516]Open DOISearch in Google Scholar
[33. Kirklin JK, Nashel DC, Pagani FD – Seventh INTERMACS annual report: a 15000 patients and counting, J Heart Lung Transplantation 2015, 34:1495-53410.1016/j.healun.2015.10.00326520247]Search in Google Scholar
[34. Colvin-Adams M, Swith JM, Heubuer BM et al – OPTSRTR 2013 annual data report: Am J Transplant 2015, 15 (suppl 2)10.1111/ajt.1319925626345]Search in Google Scholar
[35. Ponikowski P, Voor AA, Anker SD – Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Assocition (HFA) of the ESC, Eur. J Heart Failure 1016, 18:891-975]Search in Google Scholar
[36. Klein L, Dorobantu L – Mechanical Circulatory Support in Current Approach to Heart Failure - Eds Dorobantu L et al, Springer 2016; pag: 311-33310.1007/978-3-319-45237-1_15]Search in Google Scholar
[37. Felman D, Pamboukian SV, Teuteberg I et al – The 2013 International Society for Heart and Lung Transplantation. Guidelines for mechanical circulatory support executive summary, J Heart Lung Transplant 2013, 22:157-82]Search in Google Scholar
[38. Boyle AJ, Ascheim DD, Russo MJ et al – Clinical outcomes for continous flow left ventricular assist device patients stratified by pre-operative INTERMACS classification, J Heart Lung Transplant 2017, 30:402-40710.1016/j.healun.2010.10.01621168346]Open DOISearch in Google Scholar
[39. Jurda UP, Kushwaha SS, Tatooles AJ et al – Results of the destination therapy post-food and drug administration approval study with a continous flow left ventricular device : a prospective study using the INTERMACS Registry, J Am Coll Cardiol 2014, 63:1751-175710.1016/j.jacc.2014.01.05324613333]Search in Google Scholar
[40. Kittleson MM – Changing role of Heart Transplantation, Heart Fail Clin 2016, 12:411-42110.1016/j.hfc.2016.03.00427371517]Search in Google Scholar
[41. Kalmanovici I et al – Management of Advanced Heart Failure, Expert Rev. Cardiovasc. Therapy, 2013, 16(11); 775-79410.1080/14779072.2018.153011230282492]Search in Google Scholar
[42. Melra MR, Canter CE, Hannan MM et al – The 2016 International Society of Heart Lung Transplantation listing criteria for heart transplantation: a 10 year up date, Heart Lung Transplant 2016, 75: 1-2310.1016/j.healun.2015.10.02326776864]Search in Google Scholar
[43.Campbell RT, Petric MC, Jackson CE et al – Which patients with heart failure should receive specialist palleative care, Eur J Heart Fail. 2018, 20: 1338-4710.1002/ejhf.1240660747929952090]Open DOISearch in Google Scholar